Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Restech Srl
Age
6–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age: 6-65 years old
Diagnosis of persistent asthma
Treatment level at study entry:
* For children 6-11 years: Step2 or Step3 of the GINA document
* For adolescents and adults 12-65 years: Step2 under daily low-dose inhaled corticosteroids (ICS), Step 3 or Step 4 of the GINA document
Uncontrolled asthma (ACQ-5 \> 1.5) that, according to the physician, does not warrant an immediate step-up of the treatment
History of moderate or severe exacerbations in the twelve (12) months prior to baseline visit
You may not be if
Use of oral, rectal or parenteral glucocorticosteroids 30 days before enrolment
Treatment with leukotriene receptor antagonist (LTRA)
Treatment with maintenance and reliever therapy (SMART/MART)
Smoking, current or previous with a history of 10 pack-years or more
Documented COPD or other concomitant clinically important diseases or cognitive impairment that, according to the physician, may interfere with the subject's ability or safety to participate in the study
For school-age children (6-11 years old): gestational age at birth \< 37 weeks or documented bronchopulmonary dysplasia (BPD)
Prolonged absence from home during the monitoring period (i.e. at recruitment, expected ≥3 consecutive weeks for ≥2 times during the 9- month monitoring period) Subject currently enrolled in other clinical trials related or involving the study of the respiratory system
History of near-fatal asthma
Women who are pregnant, nursing or intending to become pregnant during the time of the study
Absence of health insurance coverage (applies to French centres only)
Clareo Health | Self-Management Of Asthma By Forced Oscillation Technique
